TOBAM’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$774K Sell
2,693
-3,695
-58% -$1.06M 0.3% 69
2025
Q1
$1.97M Sell
6,388
-11,834
-65% -$3.65M 0.84% 43
2024
Q4
$6.43M Sell
18,222
-19,719
-52% -$6.96M 1.96% 13
2024
Q3
$13.6M Sell
37,941
-18,317
-33% -$6.56M 2.48% 4
2024
Q2
$17.9M Sell
56,258
-52,389
-48% -$16.7M 2.81% 3
2024
Q1
$25M Sell
108,647
-5,110
-4% -$1.17M 2.24% 17
2023
Q4
$25M Sell
113,757
-31,663
-22% -$6.96M 2.19% 18
2023
Q3
$32.8M Sell
145,420
-3,073
-2% -$694K 2.64% 9
2023
Q2
$32.8M Sell
148,493
-21,430
-13% -$4.73M 2.47% 11
2023
Q1
$38.1M Buy
169,923
+60,639
+55% +$13.6M 2.51% 9
2022
Q4
$30.4M Buy
109,284
+67,767
+163% +$18.8M 2.01% 16
2022
Q3
$8.69M Buy
41,517
+37,750
+1,002% +$7.9M 0.61% 54
2022
Q2
$888K Buy
+3,767
New +$888K 0.06% 136
2019
Q1
Sell
-17,080
Closed -$1.86M 160
2018
Q4
$1.86M Sell
17,080
-18,915
-53% -$2.06M 0.09% 103
2018
Q3
$4.6M Sell
35,995
-8,157
-18% -$1.04M 0.2% 89
2018
Q2
$5M Buy
44,152
+8,874
+25% +$1M 0.21% 89
2018
Q1
$3.96M Buy
35,278
+3,035
+9% +$341K 0.16% 100
2017
Q4
$4.77M Sell
32,243
-35,156
-52% -$5.2M 0.21% 89
2017
Q3
$7.9M Sell
67,399
-356
-0.5% -$41.7K 0.3% 78
2017
Q2
$8.79M Buy
67,755
+8,820
+15% +$1.14M 0.33% 66
2017
Q1
$7.98M Sell
58,935
-14,528
-20% -$1.97M 0.31% 69
2016
Q4
$10.5M Sell
73,463
-53,984
-42% -$7.74M 0.43% 60
2016
Q3
$15M Buy
127,447
+59,275
+87% +$7M 0.54% 56
2016
Q2
$7.22M Sell
68,172
-31,239
-31% -$3.31M 0.29% 62
2016
Q1
$11.1M Sell
99,411
-54,648
-35% -$6.09M 0.44% 59
2015
Q4
$24.1M Sell
154,059
-22,314
-13% -$3.49M 1.04% 32
2015
Q3
$23.1M Sell
176,373
-71,693
-29% -$9.41M 0.9% 40
2015
Q2
$43.2M Buy
+248,066
New +$43.2M 1.57% 22